A study analyzing 69 patients with gastric neuroendocrine tumors (GNETs) showed a favorable prognosis, with 5-year survival rates at 93.8% and recurrence rates at 7.25%. Most tumors were grade 1 and type I, with treatment variations between tumor grades; grade 1 patients often opted for endoscopic treatment, while grade 2 received surgical or chemotherapeutic interventions. Patients exhibiting margin positivity or deep tumor invasion had a higher likelihood of recurrence, indicating the need for close monitoring.
Journal Article by Zheng Q, Kim JY (…) Chung H et 2 al. in Gut Liver